UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week…
Geopolitical Volatility Surges into Top 10 Business Risks for the First Time, Aon’s Global Study Finds
19th year of survey reveals cybersecurity remains top concern as workforce-related risks…
CeraVe and L’Oral Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study
New findings reveal critical microbial drivers, ethnic variations, and new pathways for…
Organogenesis Provides Update on Second Phase 3 ReNu Study
Company maintains confidence in ReNu as innovative pain management therapy Second Phase…
DXC Ranked a Leader in ISG Provider Lens ServiceNow Ecosystem Partners 2025 Study
DXC is ranked a leader across all categories in the US, AP&J,…
Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease
MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a…
9 in 10 CEOs See a Stronger Business Case for Sustainability; Nearly All Plan to Maintain or Expand Commitments, UN Global Compact-Accenture 2025 CEO Study Finds
CEOs call for a new era of pragmatic execution that embeds sustainability…
RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma
Marks a significant milestone in ongoing collaboration between RadioMedix and Vect-Horus to…
Booking Health Expands Access to Dendritic Cell Therapy After Study Confirms Survival Benefit in Glioblastoma Patients
September 09, 2025 13:19 ET | Source: Booking Health Langenfeld, Germany, Sept.…
Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announce Documentary, “An Inconvenient Study”
WASHINGTON, DC, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Informed Consent Action…
